Abstract
Isozymes are enzymes that catalyze identical biological reactions, yet exhibit slight variations in structures and catalytic efficiency, which enables the precise adjustment of metabolism to fulfill the specific requirements of a particular tissue or stage of development. Methionine aminopeptidase (MetAP) isozymes function a critical role in cleaving N-terminal methionine from nascent proteins to generate functional proteins. In humans, two distinct MetAP types I and II have been identified, with type I further categorized into cytosolic (MetAP1) and mitochondrial (MetAP1D) variants. However, despite extensive structural studies on both bacterial and human cytosolic MetAPs, the structural information remains unavailable for human mitochondrial MetAP. This study was aimed to elucidate the high-resolution structures of human mitochondrial MetAP1D in its apo-, cobalt-, and methionine-bound states. Through a comprehensive analysis of the determined structures and a docking simulation model with mitochondrial substrate peptides, we present mechanistic insights into the cleavage process of the initiator methionine from mitochondrial proteins. Notably, despite the shared features at the active site between the cytosolic and mitochondrial MetAP type I isozymes, we identified distinct structural disparities within the active-site pocket primarily contributed by two specific loops that could play a role in accommodating specific substrates. These structural insights offer a basis for the further exploration of MetAP isozymes as critical players in cellular processes and potential therapeutic applications.
Introduction
Protein maturation is a fundamental cellular process, with the removal of the initial N-terminal methionine being one of the earliest modifications for approximately 70% of proteins. This reaction is catalyzed by methionine aminopeptidases (MetAPs). In humans, three MetAP isozymes exist: the cytosolic MetAP1 and MetAP2, and the mitochondrial MetAP1D. While cytosolic MetAPs are well-characterized, the structural basis for MetAP1D function has remained elusive. This knowledge gap is particularly significant given that MetAP1D is upregulated in several cancers, including colon and breast cancer, suggesting its potential as a therapeutic target. Understanding the unique structural features of MetAP1D is essential for developing selective inhibitors that do not interfere with essential cytosolic counterparts.
Methods
The research team determined high-resolution crystal structures of human MetAP1D in three states: apo (1.51 Å), cobalt-bound (1.39 Å), and methionine-bound (1.45 Å). These structures were deposited in the PDB under IDs 8KHM, 8KHN, and 8KHO. To understand substrate recognition, docking simulations were performed using mitochondrial substrate peptides (e.g., Met-Pro-Gln). Comparative structural and sequence analyses were conducted against human MetAP1, MetAP2, and bacterial homologs to identify distinguishing features.
Results
Structural Architecture and the "Pita-Bread" Fold
MetAP1D adopts the classic "pita-bread" fold, characterized by a central active site pocket flanked by alpha-helices. A key finding is the significantly more negative surface potential of MetAP1D compared to MetAP1. This electrostatic property likely facilitates the recruitment of positively charged mitochondrial targeting signals into the active site.
Unique "Forceps-like" Loops and Substrate Selectivity
The study identified two specific loops, α1-α2 and β6-β7, that differ significantly from those in cytosolic MetAP1. These loops act like forceps to position the substrate peptide. Sequence alignments highlight these divergent regions, particularly the β6-β7 loop, which contribute to the enzyme's specific substrate preferences. Docking simulations suggest a preference for small, uncharged residues at the P1' position (e.g., Pro, Thr, Ala), influenced by the unique environment created by residue Ile286.
Catalytic Mechanism
The high-resolution snapshots of the active site (Figure 1c) allow for a detailed proposal of the catalytic mechanism. The process involves a metal-bridging water molecule acting as a nucleophile to attack the peptide bond, with Glu284 serving as a general base. The wider and shallower entrance groove of MetAP1D compared to MetAP1 may accommodate a broader range of mitochondrial protein precursors.
Discussion and Conclusion
This study provides the first high-resolution structural framework for understanding human mitochondrial MetAP1D. The identification of unique loop structures and surface charge distributions offers specific "druggable" features for future therapeutic development. Future work should focus on structures with native metals (e.g., Mn or Fe) and longer, more complex mitochondrial precursor proteins to fully elucidate the recognition dynamics. These insights pave the way for high-throughput screening of selective MetAP1D inhibitors.
Summary updated